Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Cancer Prev Res (Phila). 2014 Aug 7;7(11):1112–1121. doi: 10.1158/1940-6207.CAPR-14-0129

Figure 3. Microbial biomarkers improve accuracy of predictive models for differentiating between healthy subjects and those with colonic lesions.

Figure 3

Adenoma and carcinoma subjects were combined into a single clinical group (Lesions; n=60). A. Relative abundance of differentially abundant OTUs for healthy (n=30; grey) subjects and those with lesions (n=60; black). The mean relative abundance is represented for each clinical group by a vertical black line. B. ROC curves for microbial biomarkers alone, clinical data alone, and microbial biomarkers with clinical data. The straight line represents the null model.